📰 Eric Mcdade News
Page 4 - Eric Mcdade News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eric Mcdade. Real-time updates on events, politics, business and more.
November 1, 2022
Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease.
November 1, 2022
Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease.
November 1, 2022
Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease.
November 1, 2022
Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease.
March 11, 2022
/PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company and its collaboration partner Eisai will both present data...
March 11, 2022
/PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company and its collaboration partner Eisai will both present data...
March 11, 2022
STOCKHOLM, March 11, 2022 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company and its collaboration partner Eisai will both present data relating
December 21, 2021
Washington University School of Medicine in St. Louis is launching an international clinical trial aimed at preventing Alzheimer's disease in people genetically destined to develop the illness at a young age. Unlike most other Alzheimer's prevention trials, this one will enroll people before the disease has taken hold - up to 25 years before the expected onset of dementia.
December 20, 2021
Neurologist Eric McDade, DO, meets with Marty Reiswig, a participant in Alzheimer’s prevention trials at Washington University School of Medicine in
December 20, 2021
Researchers at Washington University School of Medicine are conducting an Alzheimer's prevention trial with young adults from high-risk families to evaluate whether an investigational drug can clear a key Alzheimer’s protein, amyloid beta, and slow or stop the disease.